🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Each subject will be given tafamidis. After swallowing a single tafamidis c...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2014-10
Trial ID
NCT02217813
Relative bioavailability study to evaluate the pharmacokinetics of two new ...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2022-07-01
Trial ID
NCT05446142
This trial is conducted in Europe. The aim of this research study is to co...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2004-11
Trial ID
NCT00184600
Treatments Being Tested
The purpose of this trial is to determine the equivalence of 3 new formulat...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00630435
The AstraZeneca Study is a single-arm, open-label, interventional, Phase 3b...
Status
Completed
Location
Botswana Harvard Health Partnership
Start Date
2021-09-15
Trial ID
NCT05715944
Treatments Being Tested
This is an open-label, single-arm, multicenter, Phase 4 study to explore th...
Status
Completed
Location
Research site
Start Date
2013-06
Trial ID
NCT01806298
Treatments Being Tested
The SUBMO-PIC01-2025 study evaluates whether SUBMO®, a submucosal injection...
Status
Recruiting
Location
Hospital Universitario de la Santa Creu i Sant Pau
Start Date
2026-04-29
Trial ID
NCT07448129
Treatments Being Tested
A substance called immunoglobulin E (IgE), which is naturally produced by o...
Status
Completed
Location
Alabama Allergy and Asthma Center
Start Date
2004-04
Trial ID
NCT00079937
Treatments Being Tested
The purpose of this study is to determine in current and non-smokers the cl...
Status
Completed
Location
Department of Periodontology
Start Date
2003-07
Trial ID
NCT00066066
Treatments Being Tested
* To evaluate the pharmacokinetic (PK) profiles of MIN-l0l following admini...
Status
Completed
Location
Biokinetic Europe
Start Date
2016-11-30
Trial ID
NCT03038646
Treatments Being Tested